|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,250.00 KRW | +3.69% |
|
+5.39% | -75.46% |
Company Valuation: TELCON RF PHARMACEUTICAL. Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 517,387 | 255,964 | 110,233 | 97,672 | 70,587 | 62,827 |
| Change | - | -50.53% | -56.93% | -11.39% | -27.73% | -10.99% |
| Enterprise Value (EV) 1 | 580,973 | 288,705 | 130,775 | 114,577 | 116,241 | 64,971 |
| Change | - | -50.31% | -54.7% | -12.39% | 1.45% | -44.11% |
| P/E | -12x | -11.1x | -2.56x | 8.52x | -2.64x | -3.84x |
| PBR | 5.81x | 2.74x | 1.31x | 0.97x | 0.85x | 0.58x |
| PEG | - | 0.2x | -0.1x | -0x | 0x | 0.1x |
| Capitalization / Revenue | 15.6x | 6.76x | 3.96x | 2.69x | 1.86x | 1.46x |
| EV / Revenue | 17.5x | 7.63x | 4.7x | 3.16x | 3.07x | 1.51x |
| EV / EBITDA | 252x | -795x | 599x | 22x | 26.2x | 11.7x |
| EV / EBIT | -278x | -63.3x | -32.2x | 119x | -1,648x | 90.4x |
| EV / FCF | -562x | -37.4x | 414x | -21.5x | 11.2x | -7.31x |
| FCF Yield | -0.18% | -2.67% | 0.24% | -4.64% | 8.9% | -13.7% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -16,772 | -8,764 | -13,233 | 3,417 | -7,417 | -2,390 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 33,141 | 37,841 | 27,830 | 36,307 | 37,865 | 43,162 |
| EBITDA 1 | 2,307 | -363.1 | 218.5 | 5,210 | 4,436 | 5,543 |
| EBIT 1 | -2,090 | -4,563 | -4,063 | 965.3 | -70.55 | 718.6 |
| Net income 1 | -40,893 | -23,098 | -42,084 | 13,906 | -26,320 | -11,456 |
| Net Debt 1 | 63,586 | 32,741 | 20,542 | 16,904 | 45,654 | 2,143 |
| Reference price 2 | 202,000.00 | 97,500.00 | 33,833.33 | 29,100.00 | 19,566.67 | 9,170.00 |
| Nbr of stocks (in thousands) | 2,561 | 2,625 | 3,258 | 3,356 | 3,608 | 6,851 |
| Announcement Date | 3/22/21 | 3/22/22 | 3/21/23 | 3/19/24 | 3/18/25 | 3/19/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 10.37M | ||
| 34.43x | 7.21x | 18.62x | 1.48% | 441B | ||
| 49.99x | 16.96x | 35.41x | -.--% | 212B | ||
| 18.77x | 0.78x | 13.6x | 2.39% | 169B | ||
| 34.62x | 10.54x | 26.2x | 0.3% | 161B | ||
| 31.16x | 5.94x | 17.38x | 1.15% | 68.61B | ||
| 148.36x | 19.1x | 56.01x | -.--% | 57.01B | ||
| 35.2x | 2.23x | 14.46x | 1.7% | 56.83B | ||
| 71.93x | 8.38x | 38.68x | -.--% | 53B | ||
| 26.32x | 5.7x | 19.72x | 1.65% | 48.13B | ||
| Average | 50.09x | 8.54x | 26.68x | 0.96% | 126.69B | |
| Weighted average by Cap. | 41.22x | 8.65x | 24.04x | 1.07% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A200230 Stock
- Valuation TELCON RF PHARMACEUTICAL. Inc.
Select your edition
All financial news and data tailored to specific country editions
















